Barbara Muzzatti1, M Antonietta Annunziata. 1. Unit of Oncological Psychology, Centro di Riferimento Oncologico IRCCS Istituto Nazionale Tumori, Aviano, Via F. Gallini, 2-33080, Pordenone, Italy.
Abstract
PURPOSE: Considering that the number of people with oncological history is constantly growing, and that cancer survivorship has very specific long-term and late (both medical and psychosocial) effects, it seems useful to have specific multidimensional instruments to measure quality of life (QoL). This contribution aims to describe the characteristics and psychometric properties of QoL assessment tools specifically designed for the condition of long-term cancer survivorship. METHODS: We queried the MEDLINE, PsycINFO, and CINAHL databases, which allowed us to identify the pertinent papers, classified by the QoL tool they refer to. We then extracted the characteristics and the psychometric properties from each study. RESULTS: From the initial 902 papers, 18 meet the selection criteria referring to eight QoL measurements. However, a multipart validation process in order to verify validity and reliability was only started for two of these tools. CONCLUSIONS: Even though clinical practice documents that long-term cancer survivors present with different symptoms and functional challenges compared to patients who are currently undergoing treatment as well as the general population, we still lack a quality of life tool that is specific for them, and that has verified psychometric properties. Even though some of the instruments we described are promising, it is necessary to continue their refinement.
PURPOSE: Considering that the number of people with oncological history is constantly growing, and that cancer survivorship has very specific long-term and late (both medical and psychosocial) effects, it seems useful to have specific multidimensional instruments to measure quality of life (QoL). This contribution aims to describe the characteristics and psychometric properties of QoL assessment tools specifically designed for the condition of long-term cancer survivorship. METHODS: We queried the MEDLINE, PsycINFO, and CINAHL databases, which allowed us to identify the pertinent papers, classified by the QoL tool they refer to. We then extracted the characteristics and the psychometric properties from each study. RESULTS: From the initial 902 papers, 18 meet the selection criteria referring to eight QoL measurements. However, a multipart validation process in order to verify validity and reliability was only started for two of these tools. CONCLUSIONS: Even though clinical practice documents that long-term cancer survivors present with different symptoms and functional challenges compared to patients who are currently undergoing treatment as well as the general population, we still lack a quality of life tool that is specific for them, and that has verified psychometric properties. Even though some of the instruments we described are promising, it is necessary to continue their refinement.
Authors: Alv A Dahl; Saevar Berg Gudbergsson; Anne Dørum; Sophie D Fosså; Astrid H Liavaag; Øystein Sørebø Journal: Qual Life Res Date: 2011-11-02 Impact factor: 4.147
Authors: Catherine M Alfano; Bonnie A McGregor; Alan Kuniyuki; Bryce B Reeve; Deborah J Bowen; Ashley Wilder Smith; Kathy B Baumgartner; Leslie Bernstein; Rachel Ballard-Barbash; Kathleen E Malone; Patricia A Ganz; Anne McTiernan Journal: Oncology Date: 2006-06-29 Impact factor: 2.935
Authors: Femke W van Dis; Floortje Mols; Ad J J M Vingerhoets; Betty Ferrell; Lonneke V van de Poll-Franse Journal: Qual Life Res Date: 2006-07-07 Impact factor: 4.147
Authors: Sophia K Smith; Sheryl Zimmerman; Christianna S Williams; John S Preisser; Elizabeth C Clipp Journal: J Clin Oncol Date: 2008-02-20 Impact factor: 44.544
Authors: Catherine M Crespi; Sophia K Smith; Laura Petersen; Sheryl Zimmerman; Patricia A Ganz Journal: J Cancer Surviv Date: 2009-12-06 Impact factor: 4.442
Authors: Maria Antonietta Annunziata; Barbara Muzzatti; Cristiana Flaiban; Lorena Giovannini; Matilde Carlucci Journal: Support Care Cancer Date: 2016-03-01 Impact factor: 3.603
Authors: Yolanda Andreu Vaillo; Andrea Conchado Peiró; Paula Martinez Lopez; María Teresa Martinez Martinez; Pilar Moreno; Leoncio Arribas Alpuente Journal: Qual Life Res Date: 2021-11-27 Impact factor: 4.147
Authors: Barbara Muzzatti; Cristiana Flaiban; Francesca Romito; Claudia Cormio; Maria Antonietta Annunziata Journal: Support Care Cancer Date: 2013-08-03 Impact factor: 3.603
Authors: Marieke van Leeuwen; Olga Husson; Paola Alberti; Juan Ignacio Arraras; Olivier L Chinot; Anna Costantini; Anne-Sophie Darlington; Linda Dirven; Martin Eichler; Eva B Hammerlid; Bernhard Holzner; Colin D Johnson; Meropi Kontogianni; Trille Kristina Kjær; Ofir Morag; Sandra Nolte; Andrew Nordin; Andrea Pace; Monica Pinto; Katja Polz; John Ramage; Jaap C Reijneveld; Samantha Serpentini; Krzysztof A Tomaszewski; Vassilios Vassiliou; Irma M Verdonck-de Leeuw; Ingvild Vistad; Teresa E Young; Neil K Aaronson; Lonneke V van de Poll-Franse Journal: Health Qual Life Outcomes Date: 2018-06-04 Impact factor: 3.186
Authors: Neil K Aaronson; Vittorio Mattioli; Ollie Minton; Joachim Weis; Christoffer Johansen; Susanne O Dalton; Irma M Verdonck-de Leeuw; Kevin D Stein; Catherine M Alfano; Anja Mehnert; Angela de Boer; Lonneke V van de Poll-Franse Journal: EJC Suppl Date: 2014-05-29